Comorbidity as a risk factor for overall survival and decision criteria for intensity of chemotherapy in elderly patients with acute myeloid leukemia.
作者:
主题词
老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);共病现象(Comorbidity);决策(Decision Making);女(雌)性(Female);随访研究(Follow-Up Studies);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);缓解诱导(Remission Induction);危险因素(Risk Factors);存活率(Survival Rate);治疗结果(Treatment Outcome)
DOI
10.1007/s12032-011-9853-8
PMID
21331819
发布时间
2021-10-20
- 浏览84
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文